Results 241 to 250 of about 18,439,231 (382)

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Assessment of ambulance interventions; proposal of a performance measurement framework for healthcare improvement in EMS response to patient collapse. [PDF]

BMC Emerg Med
Idris K, Mubeen Z, Shaikh ZN, Latif A, Hasan S, Khan A.   +5 more
europepmc   +1 more source

Establishing a Foundation for Performance Measurement for Local Public Health Preparedness. [PDF]

Disaster Med Public Health Prep, 2022
Schlegelmilch J, Stripling M, Chandler T, Marx S, Gu PB.   +4 more
europepmc   +1 more source

THERMAL PERFORMANCE MEASUREMENTS OF A GRAPHITE TUBE COMPACT CRYOGENIC SUPPORT FOR THE SUPERCONDUCTING SUPER COLLIDER [PDF]

, 1988
J. D. Gonczy, William N. Boroski, E. Larson, T. Nicol, R. C. Niemann, J. Otavka, M. Ruschman   +6 more
openalex   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

Molecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova, Dominika Maurencova, Barbora Salovska, Marek Kratky, Tomas Mracek, Zuzana Korandova, Alena Pecinova, Pavla Vasicova, David Rysanek, Ladislav Andera, Ivo Fabrik, Rudolf Kupcik, Pavel Kashmel, Pinky Sultana, Vojtech Tambor, Jiri Bartek, Josef Novak, Marie Vajrychova, Zdenek Hodny   +18 more
wiley   +1 more source

Primary care performance measurement in Brazil (Previne Brasil Program), 2022-2023. [PDF]

BMC Health Serv Res
de Souza CDF, do Nascimento ALO, de Souza CAJ, Machado MF, Araújo MDP, de Albuquerque Wanderley R, Teixeira CP, do Carmo RF.   +7 more
europepmc   +1 more source

Validity and Test-retest Reliability of the Jumpo App for Jump Performance Measurement. [PDF]

Int J Exerc Sci, 2021
Vieira A, Blazevich AJ, DA Costa AS, Tufano JJ, Bottaro M.   +4 more
europepmc   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

A transparent and standardized performance measurement platform is needed for on-prescription digital health apps to enable ongoing performance monitoring. [PDF]

PLOS Digit Health
Welzel C, Brückner S, Brightwell C, Fenech M, Gilbert S.   +4 more
europepmc   +1 more source

S-PI: A performance measurement system using an S-curve. [PDF]

MethodsX, 2021
Leal JE, Krakovics F, Vieira VDN.
europepmc   +1 more source